Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2005
12/13/2005US6974797 Bactericides for drug resistant bacteria
12/13/2005US6974796 Therapeutic compositions for treatment of a damaged tissue
12/13/2005US6974788 Zeolite Y alkylation catalysts
12/13/2005US6974668 antitumor agent binds to base DNA or RNA sequence; measure cytolysis of tumor cells; drug screening
12/13/2005US6974596 Comprising cedrol, cedrenol, farnesol, patchouli alcohol or vetiverol; antiallergic agents and atopic dermatitis preventives
12/13/2005US6974595 Pharmaceutical compositions based on Diclofenae
12/13/2005US6974594 Method of preparing biological materials and preparations produced using same
12/13/2005US6974593 Spraying a compressed fluid comprising a water insoluble active material in solvent, into an aqueous solution comprising a surfactant, forming microparticles; increase the drug bioavailability
12/13/2005US6974590 Sublingual buccal effervescent
12/13/2005US6974589 Neutral-cationic lipid for nucleic acid and drug delivery
12/13/2005US6974588 Transdermal patch for delivering volatile liquid drugs
12/13/2005US6974585 Film-forming cyanoacrylate with mixture of antibiotics for forming antibiotic containing film in situ over mammalian tissue
12/13/2005US6974583 Used to prevent or combat the harmful effects of UV and/or pollution on the skin, loss of firmness and/or elasticity of the skin, etc.
12/13/2005US6974576 Extracts provided by the present invention have a higher immune stimulatory activity than extracts prepared and used in the art
12/13/2005US6974568 Treatment for cough
12/13/2005US6974327 Double imputation scale
12/13/2005US6973741 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
12/13/2005CA2442479C Topical compositions for prostaglandin e1 delivery
12/13/2005CA2435729C New film coating
12/13/2005CA2314571C Methods and compositions for treating diseases and conditions of the eye
12/13/2005CA2280151C Arylsulfonyl hydroxamic acid derivatives
12/13/2005CA2278521C Two phase skin preparations comprising lipophilic and hydrophilic components
12/13/2005CA2271054C Substituted phenols and thiophenols useful as antioxidant agents
12/13/2005CA2240271C Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia
12/13/2005CA2234066C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
12/13/2005CA2227237C N-(aroyl)glycine hydroxamic acid derivatives and related compounds
12/13/2005CA2171003C Process for preparing n-(2,6-dichloro-3-methylphenyl)-5-7-dihalo[1,2,4]triazolo[1,5a]pyrimidine-2-sulfonamide by cyclization and halo-dehydroxylation
12/13/2005CA2147274C Transdermal therapeutic system for administering physostigmin through the skin, and method of producing the system
12/11/2005CA2566213A1 Substantially pure 2-{[2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl]-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an ikb kinase inhibitor
12/11/2005CA2467769A1 Methods and formulations for testosterone suppression
12/10/2005CA2507847A1 Prostaglandin reductase
12/10/2005CA2507738A1 Modulation of peroxisome proliferator-activated receptors
12/09/2005WO2005123108A2 Advanced vitamins and protein based nutritional supplements
12/09/2005CA2514687A1 Advenced vitamin c-based composition with enhanced biotransformation and utilization of protein and l-carnitine for nutritional supplementation or the like
12/09/2005CA2470417A1 Use of cortiocosteriods alone or in conjunction with nutritional therapy to reduce stress in animals
12/08/2005WO2005117242A1 Method and installation means for installing an electrical machine
12/08/2005WO2005116653A2 Modulators of human g protein-coupled receptors for the treatment of hyperglycemia and related disorders
12/08/2005WO2005116640A2 Identification of anti-prion drugs by high-throughput screening based on sift
12/08/2005WO2005116269A1 Method of screening sample having antiviral activity against virus with ability to infect organism exhibiting acquired immune mechanism by use of individual organism, or its cultured cell, exhibiting natural immune mechanism only, and method of estimating the antiviral activity by use of individual organism, or its cultured
12/08/2005WO2005116212A2 Treatment of neurodegenerative disease through intracranial delivery of sirna
12/08/2005WO2005116210A2 Stat6 inhibiting sirna and shrna for use in the treatment of allergic diseases, pathological changes of the respiratory system and cancer
12/08/2005WO2005116207A1 Telomerase-inhibitory ena oligonucleotide
12/08/2005WO2005116204A1 Polynucleotide causing rna interfere and method of regulating gene expression with the use of the same
12/08/2005WO2005116088A2 Methods and compositions for treating diseases and disorders associated with siglec-8 expressing cells
12/08/2005WO2005116087A1 Gel-forming polysaccharide from psyllium seed husks
12/08/2005WO2005116059A1 Method of producing highly pure teicoplanin
12/08/2005WO2005116047A2 2-substituted 17-imino estrogen compounds for cytoprotection
12/08/2005WO2005116045A1 Compositions and processes using sirna, amphipathic compounds and polycations
12/08/2005WO2005116042A1 Treatment and prevention of cancer with new ginsenoside derivatives
12/08/2005WO2005116036A1 Curcumol derivatives, the compositions comprising the same and the use of the same in the manufacture of medicament
12/08/2005WO2005116035A1 Pyrrolopyrimidine derivatives useful in cancer treatment
12/08/2005WO2005116034A1 Tetraazabenzo[e]azulene derivatives and analogs thereof
12/08/2005WO2005116028A2 Bicyclic heterocycles as kinase inhibitors
12/08/2005WO2005116027A2 Indazole and indolone derivatives and their use as pharmaceuticals
12/08/2005WO2005116024A1 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as mao inhibitors for the treatment of bacterial infections
12/08/2005WO2005116019A1 Thioether derivatives, their manufacture and use as pharmaceutical agents
12/08/2005WO2005116018A1 TYROSINE DERIVATIVES SUBSTITUTED BYALKANOYLAS hPPARα & hPPARϜ ANGONISTS
12/08/2005WO2005116015A1 Chromanol derivatives, method for the production thereof, and use thereof as an anti-inflammatory drug
12/08/2005WO2005116013A1 Crystal of pharmaceutical compound
12/08/2005WO2005116012A1 Pyrrolidine derivative
12/08/2005WO2005116010A1 Ep4 receptor agonist, compositions and methods thereof
12/08/2005WO2005116009A1 Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors
12/08/2005WO2005116005A1 Epigallocatechin dimer and trimer having lipase inhibitory activity and/or antioxidative activity
12/08/2005WO2005116002A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/08/2005WO2005115999A1 Tyrosine derivatives substituted by n-phenylacryloyl as agonists of hppar alpha and hppar gama
12/08/2005WO2005115998A1 TYROSINE DERIVATIVES SUBSTITUTED BY ALKANOYLAS hPPARα & hPPARϜ ANGONISTS
12/08/2005WO2005115996A1 Sulfamic acid ester compounds useful in the inhibition of seroid sulphatase activity and aromatase activity
12/08/2005WO2005115993A1 Quinazoline derivative
12/08/2005WO2005115991A1 Anti-cytokine heterocyclic compounds
12/08/2005WO2005115990A1 Cinnamide compound
12/08/2005WO2005115987A1 Therapeutic compounds: pyridine n oxide scaffold
12/08/2005WO2005115986A1 Therapeutic compounds: pyridine as scaffold
12/08/2005WO2005115983A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders
12/08/2005WO2005115982A1 Process for producing a dipeptidyl peptidase iv inhibitor
12/08/2005WO2005115977A1 Pyrrolidine derivatives as cb1-receptor antagonists
12/08/2005WO2005115976A1 3-amino-2-phenylpyrrolidine derivatives
12/08/2005WO2005115975A1 Arylalkylamines and process for production thereof
12/08/2005WO2005115972A1 Therapeutic compounds
12/08/2005WO2005115611A1 Adsorbent and process for producing the same
12/08/2005WO2005115548A2 Treating depressive disorders with carbonic anhydrase activators
12/08/2005WO2005115547A2 Myricitrin compounds for sleeping disorders
12/08/2005WO2005115546A2 Dimethyl sulfone for the treatment of rosacea
12/08/2005WO2005115487A1 Enhanced disinfecting compositions for medical device treatments
12/08/2005WO2005115480A2 Modified protein kinase a-specific oligonucleotides and methods of their use
12/08/2005WO2005115472A2 Compositions comprising gamma-linolenic acid and iodine for improving breast health in women
12/08/2005WO2005115471A2 Methods and compositions for treatment of nicotine dependence and dementias
12/08/2005WO2005115470A2 PHARMACEUTICAL COMPOSITIONS COMPRISING β-CARBOLINE DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF CANCER
12/08/2005WO2005115469A2 Estrogen modulation of ifn-gamma-mediated conditions and diseases
12/08/2005WO2005115468A1 Novel drug discovery target and medicine acting on the same
12/08/2005WO2005115467A1 Combinations comprising antimuscarinic agents and beta-adrenergic agonists
12/08/2005WO2005115466A1 Combinations comprising antimuscarinic agents and corticosteroids
12/08/2005WO2005115465A1 Combinations comprising antimuscarinic agents and pde4 inhibitors
12/08/2005WO2005115464A1 Combinations comprising antimuscarinic agents and corticosteroids
12/08/2005WO2005115463A1 Combinations comprising antimuscarinic agents and beta-adrenergic agonists
12/08/2005WO2005115462A1 Combinations comprising antimuscarinic agents and pde4 inhibitors
12/08/2005WO2005115455A2 Methods and reagents for the treatment of immunoinflammatory disorders
12/08/2005WO2005115450A1 Compositions comprising demethylating agents as enhancers of immunotherapy for the treatment of chronic infections and neoplastic diseases and methods for treating the same
12/08/2005WO2005115443A1 Chronic articular inflammation-modulating composition based on collagen-polyvinylpyrrolidone
12/08/2005WO2005115441A2 Compositions and methods for enhanced mucosal delivery of parathyroid hormone
12/08/2005WO2005115428A2 Supplement containing carotenoid, nicotinamide, zinc, water soluble extract of uncaria species and method using the same
1 ... 4438 4439 4440 4441 4442 4443 4444 4445 4446 4447 4448 4449 4450 4451 4452 4453 4454 4455 4456 4457 4458 ... 7860